Cigna vs Primerica Which Is a Smarter Choice?

Cigna and Primerica are both prominent players in the financial services industry, with Cigna focusing on health insurance and Primerica specializing in financial products and services. When comparing these two companies' stocks, investors must consider various factors such as financial performance, market trends, and industry competition. Both Cigna and Primerica have shown stability and growth potential in recent years, making them attractive options for investors looking to diversify their portfolios within the financial services sector.

Cigna or Primerica?

When comparing Cigna and Primerica, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Cigna and Primerica.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Cigna has a dividend yield of 2.12%, while Primerica has a dividend yield of 1.02%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Cigna reports a 5-year dividend growth of 161.81% year and a payout ratio of 64.59%. On the other hand, Primerica reports a 5-year dividend growth of 21.06% year and a payout ratio of 23.16%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Cigna P/E ratio at 37.52 and Primerica's P/E ratio at 22.19. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Cigna P/B ratio is 2.13 while Primerica's P/B ratio is 5.19.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Cigna has seen a 5-year revenue growth of 2.37%, while Primerica's is 0.81%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Cigna's ROE at 5.59% and Primerica's ROE at 21.89%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $316.77 for Cigna and $295.75 for Primerica. Over the past year, Cigna's prices ranged from $253.95 to $370.83, with a yearly change of 46.02%. Primerica's prices fluctuated between $184.76 and $304.84, with a yearly change of 64.99%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.